Investor relations

An investment in Bio-Works allows participation in the expansive biotechnology sector but with a lower risk profile.

Bio-Works generates revenue in the early phases of a biotherapeutics’ development, long before the approval of the drug substance.

There is a strong market demand for suppliers of chromatography resins who can offer alternatives to the few that have dominated the market for decades.

Bio-Works has the foundational cornerstones in place and is well-positioned for expansive growth without large investments in the near future.